Helping You Build Wealth With Honest Research
Since 1996. Try Now


Invalid Username / Password
Invalid Captcha
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Investment in securities market are subject to market risks. Read all the related documents carefully before investing

An Emerging Opportunity for Investors
India's Lithium Megatrend

**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
**By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.


Sensex Today Crosses 70,000 Mark | IRFC Jumps 4% | ONGC & Coal India Top Gainers
Mon, 11 Dec 10:30 am

Sensex Today Crosses 70,000 Mark | IRFC Jumps 4% | ONGC & Coal India Top Gainers

Asian shares slipped on Monday ahead of a week packed with a quintet of central bank meetings and data on US inflation.

The Nikkei is trading 1.6% higher while the Hang Seng index is trading 1.7% lower.

US stocks notched their highest closing levels since early 2022 after a robust US jobs report fuelled investor optimism about a soft landing for the economy.

Here's a table showing how US stocks performed on Friday:

Stock/IndexLTPChange ($)Change (%)Day HighDay Low52-Week High52-Week Low
Dow Jones36,247.9130.50.4%130.50.036,296.231,429.8
Source: Equitymaster

At present, the BSE Sensex is trading 77 points higher and NSE Nifty is trading flat.

ONGC and Coal India are among the top gainers today.

Cipla and Asian Paints on the other hand are among the top losers today.

Broader markets are trading on positive note. The BSE Mid Cap index is trading 0.5% higher and the BSE Small Cap index is trading higher by 0.7%.

Barring healthcare sector all other sectoral indices are positive today, with stocks in realty sector and energy sector witnessing most buying.

Shares of L&T Technology, IndusInd Bank hit their 52-week high today.

The rupee is trading at Rs 83.38 against the US dollar.

--- Advertisement ---
Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Special Replay of Today's Event for You

Today, Rahul shared his entire research on this mega opportunity that he calls India's third giant leap.

He also showed how this leap could potentially generate wealth at a scale we have probably never seen before.

Plus, he also shared details of his latest special report covering his top 3 stocks to ride this giant leap with all the viewers.

And also gave hints about 10 more stocks.

If you missed all this crucial information, then you can click here to watch the special replay of the event.

Click Here To Watch Now
Details of our SEBI Research Analyst registration are mentioned on our website -

In commodity markets, gold prices are trading 0.2% lower at Rs 61,618 per 10 grams today.

Meanwhile, silver prices are trading 0.3% lower at Rs 72,329 per 1 kg.

Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...

Speaking of stock markets, when it comes to famous turnarounds of the last one year, no discussion can be complete without Suzlon Energy.

The stock was arguably on the top of the list of every market pundit.

For perspective, the stock is up a whopping 312% in the last one year, far outperforming the close to 40% returns earned by the BSE Small Cap index.

By the way, it is up a huge 20x from its March 2020 lows. Talk of life changing investments!

However, there is a risk to investing in a stock like Suzlon Energy and ignoring this risk could prove fatal over the long run.

Co-head of research, Rahul Shah, in his latest video talks about what exactly is this risk and how should one minimise it.

Tata Motors to Hike Prices

Tata Motors on 10 December said that it will increase the price of its commercial vehicles effective from 1 January 2024, up to 3%.

The price increase is to offset the residual impact of the past input costs and will be applicable across the entire range of commercial vehicles.

Tata Motors sells a range of passenger vehicles starting with the hatchback Tiago to the premium SUV Safari priced between Rs 560,000 and Rs 2.6 m.

The company joins the likes of Maruti Suzuki, Mahindra & Mahindra, Honda and Audi among others, which have also announced plans to increase vehicle prices in January.

Must Read: India's Lithium Megatrend is an Emerging Opportunity for Investors

India has mandated automakers to comply with stricter fuel efficiency norms from April this year and will also require all cars to have six airbags by October.

Meanwhile, even as key commodity prices have come off record levels, automakers have been resorting to price hikes to shore up margins in a high-inflation environment.

Tata Motors stock price hits record high in October. To know what's driving the rally, check out Why Tata Motors Share Price is Rising.

To know, if has Tata Motors become immune to all cycles, check out Tata Motors: The Mistake That Can Cost You a Lot of Money.

As you're interested in Tata group stocks, check out the new section in our Stock Screener, where you can view the fundamentals of companies within a business group in one screen, including the Top Tata group stocks.

Cipla's arm recalls drug

Pharma major Cipla's wholly-owned subsidiary InvaGen Pharmaceuticals USA voluntarily recalled one lot of Vigabatrin for oral solution USP - 500 mg to the consumer level due to seal integrity issues that could lead to powder leakage from the pouch.

The product is used for the treatment of refractory complex partial seizures as adjunctive therapy in patients 2 years of age and older who have responded adequately to several alternative treatments.

The medication is packaged in foil pouches, each containing 500 mg of Vigabatrin, and there are 50 foil-sealed pouches in a shelf pack.

--- Advertisement ---
Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Your Invitation to Access

Our Small Business Stock Research is Still Open

Get Access Now
Details of our SEBI Research Analyst registration are mentioned on our website -

InvaGen Pharmaceuticals is notifying the customer level through press releases, letters, telefax, telephone, email, and on-site visits and is coordinating the return of all recalled products.

In case any adverse reactions or quality problems are experienced with the use of this product, Cipla said that the same can be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax. Till date, Cipla has not received any reports of adverse events related to this recall.

Pharmaceutical giant Cipla is reportedly exploring a stake sale, and contenders are cropping up in an intense competition. For more, check out Cipla Promoter Stake Sale: Billions of Dollars in Play.

It is among the Top 5 Nifty 50 Stocks that Beat Earnings Estimates by a Wide Margin in Q1.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sensex Today Crosses 70,000 Mark | IRFC Jumps 4% | ONGC & Coal India Top Gainers". Click here!